Ortin Global Ltd (NSE:ORTINGLOBE) Share Price

Company Profile

Business description
Ortin Global Ltd is an Indian company engaged in the manufacturing and trading of Pharmaceuticals, Drugs, and Intermediates. Its formulations include anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, antibiotics, antifungal, cephalosporins, and others. Some of its API intermediates include Ciprofloxacin, Tramadol, Efavarenz, Lamivudine, Zudavudine, Nevirapine, Lopinavir, Fluconazole, Triclabendazole, Omeprazole, and others. The company has two operating segments, including Manufacture and Trading. The company generates the majority of its revenue from the Trading division, which involves trading of Pharmaceuticals and medical Formulations.
Contact
Road No.12, Mayfair Gardens
8-2-682/3/A & 3B, Flat No. 201, 2nd Floor
Banjara Hills, Khairatabad
HyderabadTG500034
IND
T: +91 4027567266
https://www.ortinlabsindia.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
2

Recommended

We are surprised that Teck agreed to the merger on these terms, and wouldn’t be surprised if there is a twist in the tale.

Jon Mills, CFA | 11 September 2025

The magnitude of growth at Broadcom continues to astound us.

William Kerwin, CFA | 10 September 2025

The banking major needs to prevent key product offerings from falling further behind the competition.

Nathan Zaia | 10 September 2025

Index	Last price	Change	% Change
All Ordinaries	9,067.50	13.00	-0.14%
CAC 40	7,761.32	11.93	0.15%
DAX 40	23,632.95	85.50	-0.36%
Dow JONES (US)	45,490.92	220.42	-0.48%
FTSE 100	9,225.39	17.14	-0.19%
HKSE	25,973.09	227.17	-0.87%
NASDAQ	21,886.06	6.57	0.03%
Nikkei 225	44,271.92	434.25	0.99%
NZX 50 Index	13,216.44	59.80	-0.45%
S&P 500	6,532.04	19.43	0.30%
S&P/ASX 200	8,800.60	13.20	-0.15%
SSE Composite Index	3,824.25	12.03	0.32%